Bny. Setty et al., Fetal hemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion, BLOOD, 97(9), 2001, pp. 2568-2573
To assess whether fetal hemoglobin (HbF) modulates the adhesion of sickle e
rythrocytes to endothelium, children with homozygous sickle cell anemia (SS
disease) were studied, using this physiologically crucial period to evalua
te the relationships between HbF and the major erythrocyte adhesion markers
. The mean level of CD36(+) erythrocytes was 2.59% +/- 2.15% (+/- SD, n = 4
0) with an inverse relationship be tween CD36 positivity and F cells (R = -
0.76, P < .000 00 002). In univariate analyses, significant correlations wi
th various hematologic parameters and age were noted. Multiple regression a
nalyses, however, revealed a relationship solely with F cells. Minimal leve
ls of very rate activation antigen-4(+) (VLA4(+)) erythrocytes (0.31% +/- 0
.45%, n = 40) with relationships similar to those noted for CD36(+) cells w
ere also observed. The subpopulation of strongly adhesive stress reticulocy
tes was further assessed, using CD71 as their marker. The mean level of CD7
1(+) erythrocytes was 5.81% +/- 4.21%, with statistical correlates in univa
riate and multivariate analyses similar to those discussed above. When adhe
sion ratios were evaluated, inverse correlations were noted between basal a
nd plasma-induced adhesion and F-cell numbers (R = -0.54, P < .0005; R = -0
.53, P < .0006, n = 39). In addition, in analyses where basal or plasma-ind
uced adhesion was the dependent variable and the independent variables incl
uded F cells and the various adhesion-related parameters, significant relat
ionships solely with F cells were noted. The results demonstrate that SS pa
tients with higher levels of F cells have concomitant decreases in the numb
ers of CD36(+), VLA4(+), and CD71(+) erythrocytes and that these findings t
ranslate into less adherent erythrocytes. These findings extend knowledge r
egarding the protective effects of HbF in the pathophysiology of sickle cel
l disease. (Blood, 2001;97: 2568-2573) (C) 2001 by The American Society of
Hematology.